Alerts will be sent to your verified email
Verify EmailGUFICBIO
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
Orchid Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
1.28 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
16.89 % | 34.65 % | 4.49 % |
|
5yr average Equity Multiplier
|
2.16 | 1.29 | 1.61 |
|
5yr Average Asset Turnover Ratio
|
0.75 | 0.74 | 0.5 |
|
5yr Avg Net Profit Margin
|
10.24 % | 35.51 % | 0.56 % |
|
Price to Book
|
4.6 | 10.36 | 2.08 |
|
P/E
|
58.07 | 57.35 | 140.35 |
|
5yr Avg Cash Conversion Cycle
|
-15.25 Days | -112.39 Days | 52.03 Days |
|
Inventory Days
|
71.73 Days | 22.82 Days | 112.47 Days |
|
Days Receivable
|
106.89 Days | 70.51 Days | 86.58 Days |
|
Days Payable
|
179.29 Days | 130.88 Days | 159.29 Days |
|
5yr Average Interest Coverage Ratio
|
8.9 | 216.76 | 3.01 |
|
5yr Avg ROCE
|
17.89 % | 45.66 % | 3.08 % |
|
5yr Avg Operating Profit Margin
|
18.12 % | 47.34 % | 11.84 % |
|
5 yr average Debt to Equity
|
0.67 | 0.03 | 0.37 |
|
5yr CAGR Net Profit
|
-2.66 % | 10.07 % | n/a |
|
5yr Average Return on Assets
|
7.7 % | 26.69 % | 1.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.5 % | 70.86 % | 69.84 % |
|
Share Pledged by Promoters
|
0.0 | 4.49 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.5 % | -4.13 % | -20.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.5 % | 1.14 % | 15.56 % |
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
Orchid Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|